Baylor College of Medicine and Texas Children’s Hospital Center for Vaccine Development have expanded their alliance with Infectious Disease Research Institute (IDRI) to accelerate the development of a Covid-19 vaccine candidate.
The partners will work on an important manufacturing step and fill sufficient vials to advance the vaccine into Phase I clinical trials.
IDRI is a non-profit health organisation with vaccine formulations and adjuvant technologies expertise, which works to supply these products to low and middle-income countries.
Baylor College of Medicine National School of Tropical Medicine associate dean Dr Maria Elena Bottazzi said: “An important and crucial step in the manufacturing of a safe and efficacious vaccine is its